title: KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study.
abstract: BACKGROUND
  The prognostic significance of KIT or platelet-derived growth factor receptor alpha (PDGFRalpha) mutations in gastrointestinal stromal tumors (GISTs) is still controversial.
  
  
  METHODS
  In all, 104 patients were diagnosed with GISTs by KIT immunoreactivity; tumor DNA was sequenced for the presence of mutations in KIT exons 9, 11, 13 and 17 and in PDGFRalpha exons 12 and 18. Disease-free survival (DFS) was analyzed in 85 radically resected patients.
  
  
  RESULTS
  KIT mutations occurred in exon 11 (69), in exon 9 (11) and in exon 17 (1). PDGFRalpha mutations were detected in exon 18 (10) and in exon 12 (3). Ten GISTs were wild type. Exon 11 mutations were as follows: deletions in 42 cases and point mutations in 20 cases and insertions and duplications, respectively, in 2 and 5 cases. A better trend in DFS was evident for duplicated and point-mutated exon 11 KIT GISTs. There was a significant association between PDGFRalpha mutations, gastric location and lower mitotic index. Moreover, PDGFRalpha-mutated GISTs seemed to have a better outcome.
  
  
  CONCLUSIONS
  Point mutations and duplications in KIT exon 11 are associated with a better clinical trend in DFS. PDGFRalpha-mutated GISTs are preferentially localized in the stomach and seem to have a favorable clinical behavior.
authors.affiliation: Centro Regionale di Genetica Oncologica, Oncologia Medica, Ancona, Italy. chiarabraconi@tiscali.it
authors.forename: C
authors.initials: C
authors.lastname: Braconi
authors.forename: R
authors.initials: R
authors.lastname: Bracci
authors.forename: I
authors.initials: I
authors.lastname: Bearzi
authors.forename: F
authors.initials: F
authors.lastname: Bianchi
authors.forename: A
authors.initials: A
authors.lastname: Costagliola
authors.forename: R
authors.initials: R
authors.lastname: Catalani
authors.forename: A
authors.initials: A
authors.lastname: Mandolesi
authors.forename: R
authors.initials: R
authors.lastname: Ranaldi
authors.forename: E
authors.initials: E
authors.lastname: Galizia
authors.forename: S
authors.initials: S
authors.lastname: Cascinu
authors.forename: G
authors.initials: G
authors.lastname: Rossi
authors.forename: L
authors.initials: L
authors.lastname: Giustini
authors.forename: L
authors.initials: L
authors.lastname: Latini
authors.forename: N
authors.initials: N
authors.lastname: Valeri
authors.forename: R
authors.initials: R
authors.lastname: Cellerino
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018572:Disease-Free Survival; D005260:Female; D046152:Gastrointestinal Stromal Tumors / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D020440:Gene Duplication; D006801:Humans; D008297:Male; D008875:Middle Aged; D008940:Mitotic Index; D017354:Point Mutation; D019009:Proto-Oncogene Proteins c-kit / Q000235:genetics*; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics*
chemical_list: D019009:Proto-Oncogene Proteins c-kit; D020796:Receptor, Platelet-Derived Growth Factor alpha